Breast-Cancer-Update-2021

Breast cancer update January 2021

With the San Antonio Breast Cancer Conference (SABCS) 2020 by AACR just completed, several new and clinical relevant phase 2 and phase 3 have been published in the Journal of the American Medical Association, Clinical Cancer Research, New England Journal of Medicine, Journal of Clinical Oncology, and Lancet Oncology. ['mediPr] provides you with an overview.
detecting metastases with psma pet in prostate cancer

Detecting metastases with PSMA-PET in prostate cancer

Conventional imaging with computed tomography (CT), magnetic resonance imaging (MRI) and bone scans, are the current standard of care for imaging prostate cancer. Accurate imaging primarily relies on nodal metastases size for detection.
Toxic vaccine disinformation_有關疫苗的虛假信息

有關疫苗的虛假信息

我最近在YouTube頻道上看到這條在2020年12月17日發佈的視頻,聲稱說明有關COVID-19疫苗的功效和風險。該視頻的內容非常不準確且具有誤導性。 令我震驚的是,該視頻已吸引了超過三十萬觀看者,其中有幾位評論者表示同意偽科學。
CANCERINFORMER
BREAKING

Therapeutic Areas

Or, sign up for our newsletter


Therapeutic Areas

Breast-Cancer-Update-2021

Breast cancer update January 2021

With the San Antonio Breast Cancer Conference (SABCS) 2020 by AACR just completed, several new and clinical relevant phase 2 and phase 3 have been published in the Journal of the American Medical Association, Clinical Cancer Research, New England Journal of Medicine, Journal of Clinical Oncology, and Lancet Oncology. ['mediPr] provides you with an overview.

[the_ad id=”45772″]

Lower-risk-MDS-patients-benefit-from-novel-drug-imetelstat

Lower-risk MDS patients benefit from novel drug, imetelstat

Myelodysplastic syndromes (MDS) are a heterogenous group of clonal haematopoietic disorders that carry a risk of progression to acute myeloid leukaemia (AML). Patients are stratified into risk groups due to the heterogeneity of the disease, which is also exemplified by median overall survival (OS) of 8.8 years for very low risk, and 0.8 years for very high risk patients. Due to symptoms such as anaemia, supportive red blood cell (RBC) transfusions are needed in 80-90% of patients during their disease course, although RBC dependence has been shown to be an adverse prognostic marker.

[the_ad id=”45772″]

MediPaper Medical Communications Agency Hong Kong Blog
1.8K Shares
Share via
Copy link
Powered by Social Snap
MediPaper Medical Communications Agency Hong Kong Blog